Clinical Trial Update: Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC

View source ↗

Summary

A clinical trial to evaluate whether peripheral blood ETASTs can predict the efficacy of chemoimmunotherapy in non-small cell lung cancer. The study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Non-Small Cell Lung Cancer, Lung Adenocarcinoma | Status: NOT_YET_RECRUITING